BYDUREON By Your Side™ is changing

This site is now operated by Bristol-Myers Squibb (BMS) and AstraZeneca (AZ), the manufacturers of Bydureon (exenatide) 2mg powder and solvent for prolonged-release suspension for injection.

Please click on the link below to be redirected to the BMS/AZ Diabetes Alliance website (www.diabetesalliance.co.uk), where patients prescribed Bydureon can access information and useful resources, including educational mailings and text message alerts through the patient information section.

Opt-out information for currently registered services

Mailing service: Write to:
Freepost RSLC-TRJS-JUJL, Brambleside, Bellbrook Industrial Estate, UCKFIELD, TN22 1QQ

SMS Alerts:
Text STOP to 07797 804007

To change the date or time of your SMS alert:
Cancel your current registration by texting STOP to 07797 804007 and then re-register for this service on the patient information section for this medicine on www.diabetesalliance.co.uk

Go to new site now

The BYDUREON By Your Side™ Programme and associated patient education materials are provided by Bristol-Myers Squibb and AstraZeneca.
Information on privacy notice, legal notice and pharmacovigilance notice will be available on the redirected page.
Date of Preparation: March 2013 1054UK13NP01216 2511701